Amgen Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 28.5B 28.2B 26.3B 26.0B
Cost of revenue 11.0B 8.5B 6.4B 6.5B
Gross profit 17.5B 19.7B 19.9B 19.5B
Operating expense
Research & development 5.1B 4.8B 4.4B 4.8B
Selling general and admin 6.0B 6.2B 5.4B 5.4B
Other operating expenses 211.4M 879M 503M 194M
Operating income 6.2B 7.9B 9.6B 9.1B
Non operating interest income
Income
Expense 2.7B 2.9B 1.4B 1.2B
Other income expense 431.2M 2.8B -814M -1.2B
Pretax income 3.9B 7.9B 7.3B 6.7B
Tax provision 442.3M 1.1B 794M 808M
Net income 3.5B 6.7B 6.6B 5.9B
Basic EPS 7.6 12.6 12.2 10.3
Diluted EPS 7.6 12.5 12.1 10.3
Basic average shares 457.7M 556.8M 559.9M 593.2M
Diluted average shares 457.7M 556.8M 559.9M 593.2M
EBITDA 11.4B 14.8B 12.2B 12.8B
Net income from continuing op. 3.5B 6.7B 6.6B 5.9B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 25 minutes

00:34
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).